[Gnso-newgtld-wg] Package 6

trachtenbergm at gtlaw.com trachtenbergm at gtlaw.com
Mon Jun 29 21:44:16 UTC 2020


+1 to Paul.  Everyone does not agree with that position.

Marc H. Trachtenberg
Shareholder
Greenberg Traurig, LLP | 77 West Wacker Drive | Suite 3100 | Chicago, IL 60601
Tel 312.456.1020
Mobile 773.677.3305
trac at gtlaw.com<mailto:trac at gtlaw.com> | http://www.gtlaw.com<http://www.gtlaw.com/>

[Greenberg Traurig]

From: Gnso-newgtld-wg [mailto:gnso-newgtld-wg-bounces at icann.org] On Behalf Of McGrady, Paul D.
Sent: Monday, June 29, 2020 4:41 PM
To: Jeff Neuman <jeff.neuman at comlaude.com>; Cheryl Langdon-Orr <langdonorr at gmail.com>
Cc: gnso-newgtld-wg at icann.org
Subject: [Gnso-newgtld-wg] Package 6

*EXTERNAL TO GT*
Hi Jeff & Cheryl,

I was under the impression that we were going to discuss Closed Generics again, but I see it is Package 6.  Is Closed Generics not on the agenda for upcoming calls?  If it is, how can we be doing the so-called “Can’t live with” exercise when the topic isn’t closed on the calls?

Also, I see that the text indicates that the WG agrees the Board instituted a ban on them in the last round.  That is not what the Board resolution says – and in fact there was much discussion on the calls and chat about how “ban” does not apply.  There were three options:  (1) make a change to non-exclusive access, (2) maintain & defer to the next round, or (3) withdraw. Is there a way to make that section reflect the actual facts before we have to undertake the so-called “can’t live with” exercise? The way it is written now essentially takes the starting position of the part of the WG that wants to censor closed generics and implies everyone agrees with it. That isn’t the case.

Best,
Paul


Taft /

Paul D. McGrady / Partner
Taft Stettinius & Hollister LLP
111 E. Wacker Drive, Suite 2800
Chicago, Illinois 60601-3713
Tel: 312.527.4000 • Fax: 312.754.2354
Direct: 312.836.4094 • Cell: 312.882.5020
https://urldefense.com/v3/__http://www.taftlaw.com__;!!DUT_TFPxUQ!U6HGrBUsfaOlZqQAwP_f4Z8j5b6SgoQukKlAhtJWyN9gouORROQBSGMu2z5tQCt0_MoMxw$ <https://urldefense.com/v3/__http:/www.taftlaw.com__;!!DUT_TFPxUQ!WfZ003NwR5MlyrcrA5sNQIVRi1CpK3G08B_AvVzpHfqM5jVengQwAujDpoyN2yGnx_E$> / PMcGrady at taftlaw.com<mailto:PMcGrady at taftlaw.com>
[https://urldefense.com/v3/__https://dg01.redatatech.com/onprem_image_fetch?cid=1016&ep=2b8abf60503911b866966ee411c730b1e093feb7b3f8954ff3befe67d974b213381dc07c341ce027648cb0af8129a9e994a0818231199c14d6fdfe92692ed886cba1fe3d826783ee9a653dcca5732a24ad509dcbe02154dbdbb9334888f9d0fa00569bb98ef66cc7a9f840bd1c009a2fe2e4bc5a33e46f8dfefceb66aa514cd14acea9811e5318f31cc882393e7f7ee5fa019ab16969286fb371e26039327bf37555b04de9825b7b4f4266189ec80036b325a44d4ffdab50a15507915fc7a1249f04a870881fe14c500c47a61d98b1e86a0d93b9444746b9__;!!DUT_TFPxUQ!U6HGrBUsfaOlZqQAwP_f4Z8j5b6SgoQukKlAhtJWyN9gouORROQBSGMu2z5tQCtxqPLcCQ$ ]

Taft Bio<https://urldefense.com/v3/__http:/www.taftlaw.com/bio/PMcGrady@taftlaw.com__;!!DUT_TFPxUQ!WfZ003NwR5MlyrcrA5sNQIVRi1CpK3G08B_AvVzpHfqM5jVengQwAujDpoyNa1Ial7E$>

[V-Card Icon]

Taft vCard<https://urldefense.com/v3/__http:/www.taftlaw.com/vcard/PMcGrady@taftlaw.com__;!!DUT_TFPxUQ!WfZ003NwR5MlyrcrA5sNQIVRi1CpK3G08B_AvVzpHfqM5jVengQwAujDpoyN9rmjG_8$>


Subscribe to our law updates<https://urldefense.com/v3/__http:/taftlaw.com/news/subscribe__;!!DUT_TFPxUQ!WfZ003NwR5MlyrcrA5sNQIVRi1CpK3G08B_AvVzpHfqM5jVengQwAujDpoyNc0ejsHA$>




To receive regular COVID-19 updates from Taft, subscribe here<https://urldefense.com/v3/__https:/www.taftlaw.com/general/subscribe__;!!DUT_TFPxUQ!WfZ003NwR5MlyrcrA5sNQIVRi1CpK3G08B_AvVzpHfqM5jVengQwAujDpoyNvUCd2HU$>. For additional resources, visit Taft's COVID-19 Resource Toolkit<https://urldefense.com/v3/__https:/www.taftlaw.com/general/coronavirus-covid-19-resource-toolkit__;!!DUT_TFPxUQ!WfZ003NwR5MlyrcrA5sNQIVRi1CpK3G08B_AvVzpHfqM5jVengQwAujDpoyNchkgzIY$>.

This message may contain information that is attorney-client privileged, attorney work product or otherwise confidential. If you are not an intended recipient, use and disclosure of this message are prohibited. If you received this transmission in error, please notify the sender by reply e-mail and delete the message and any attachments.

----------------------------------------------------------------------
If you are not an intended recipient of confidential and privileged information in this email, please delete it, notify us immediately at postmaster at gtlaw.com, and do not use or disseminate the information.
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://mm.icann.org/pipermail/gnso-newgtld-wg/attachments/20200629/04964462/attachment-0001.html>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image001.jpg
Type: image/jpeg
Size: 6399 bytes
Desc: image001.jpg
URL: <http://mm.icann.org/pipermail/gnso-newgtld-wg/attachments/20200629/04964462/image001-0001.jpg>


More information about the Gnso-newgtld-wg mailing list